Dr. Govind Kulkarni is M.D in Internal medicine from India 1995-96. He completed cardiology research fellowship at Sydney University in 1996-97. He is founder of Pulse diabetes obesity and cardiac relief centre, Pune India. He is having interest in clinical research. He was principal investigator /co investigator of multiple diabetic and cardiac drug trials. He was co investigator for multiple new oral anti diabetic drugs. He is running obesity reduction program in Pune. His special interest is in reversal of diabetes and obesity. He is senior consulting physician and metabolic disorder consultant in MAJOR HOSPITALS PUNE, MAHARASHTRA, INDIA.

He was principal investigator /co investigator of multiple diabetic and cardiac drug trials like ENGAGE AF FOR NEW ORAL ANTICOAGULANTS and other FOURIER STUDY for new lipid lowering injectable drug PCSK9 INHIBITORS.

Dr. Shaodong Guo is Associate Professor in the Department of Nutrition and Food Science at Texas A&M University College. He received his Ph.D in Physiology from Peking University, China. Then he completed his postdoctoral research training in Genetics, Biochemistry, and Medicine in the Chinese Academy of Sciences, the University of Illinois at Chicago, and Harvard University, respectively. Dr. Guo was an Instructor in Medicine at Children's Hospital Boston and Harvard Medical School for two years prior to joining the faculty at Texas A&M Health Science Center. Currently, Dr. Guo serves as senior editor for the Journal of Endocrinology and Journal of Molecular Endocrinology, two major official journals of Endocrine Society of Europe, UK, and Australia, and he is the textbook chapter writer for Metabolic Syndrome edited by Rexford Ahima and published by Springer in 2016. He is a recipient of ADA junior faculty award, career development award, and Richard R. Lee Award. His work has been published in a number of journals including the JBC, Endocrinology, Hypertension, Diabetes, Circulation Research, AJP, MCB, and Nature Medicine, receiving more than 5,000 citations from the Google Scholar.

His research focuses on insulin/glucagon and estrogen signal transduction, insulin resistance, gene transcriptional control of nutrient homeostasis, and cardiac dysfunction in diabetes. Dr. Guo has been working on the gene transcriptional regulation of metabolic homeostasis by insulin receptor substrate proteins (IRS) and Forkhead FoxO transcription factors and he has been funded by American Diabetes Association (ADA), American Heart Association, and the National Institute of Health of USA.

Richard W.M. Visser DC, Ph.D.present workind as the CEO of VERA Health and Former Minister of Health and Sports. Bachelor of Science (B.S.) in Business Administration, St. Michael’s College, Vermont, U.S.A., 1984 – 1988 Premedical Program, University of Colorado, U.S.A., 1988 – 1989 Doctor of Chiropractic (D.C.), Palmer College of Chiropractic-West, Santa Clara, California, U.S.A., 1989 – 1993 Doctor in Medical Sciences, (PhD), Public Health National School, Havana, Cuba, Public Health Program His work has made vital contributions to a greater understanding of the biological, sociological, and psychological factors surrounding childhood obesity. Having written numerous articles on the subject for professional journals. Today Dr. Visser continues his innovative approach to healthcare by converging the exponential technological development going on right now with never before seen global connectivity.

Richard Visser has focused on the pandemic of childhood obesity among various populations, working in consultation with other international experts. He studied the problem and implemented solutions from many perspectives: as a clinical researcher, academic and educator, activist and politician, entrepreneur, concerned citizen and parent. His work has made vital contributions to a greater understanding of the biological, sociological, and psychological factors surrounding childhood obesity.

Dr Moy teaches Research Methodology, Clinical Epidemiology & Evidence-Based Medicine to both undergraduate and postgraduate candidates. Her research interests include Translational Research in the prevention of non-communicable diseases (NCDs) in the community setting, Workplace Wellness and the effects of lifestyle behaviours on NCDs. She has generated research grants amounting to more than RM3 million. She published more than 80 manuscripts in peer review journals. She initiated and established the University of Malaya Wellness Program in 2008 and coordinated the program until 2013. She is a member of the editorial board of the Malaysian Journal of Nutrition. She also reviews manuscripts for both local and international journals.

Foong Ming Moy research interests include Translational Research / Trials in the prevention of non-communicable diseases in the community setting, Workplace Wellness and the effects of lifestyle behaviors on non-communicable diseases. Currently, she heads a cohort study comprising of almost 15,000 teachers from the Peninsular Malaysia.